PATENT CLAIM ANALYSIS

Application Number: 16242897
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["800", "278000"]

Abstract:
The inventive technology relates to systems and methods for enhanced in vivo production, accumulation and modification of cannabinoids. In one embodiment, the invention may include systems and methods for enhanced in vivo biosynthesis of chemically-modified water-soluble cannabinoids in a whole plant, or a cell suspension culture system.

Claim (Index 167):
The method of  claim 164  wherein the nucleotide sequence encoding at least one cytosolic directed cannabinoid synthase having the trichome targeting sequence disrupted or removed is selected from the group consisting of: a cytosolic directed CBG synthase having the trichome targeting sequence disrupted or removed; a cytosolic directed THCA synthase having the trichome targeting sequence disrupted or removed, a cytosolic directed CBDA synthase having the trichome targeting sequence disrupted or removed, a cytosolic directed CBCA synthase having the trichome targeting sequence disrupted or removed, and any combination of the aforementioned cytosolic directed cannabinoid synthases having their respective trichome targeting sequences disrupted or removed.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 99.0
- Lexical Diversity: 1.40541
- Patent Class: 800.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['16110728', '14232465', '14510232', '15321585', '13641272']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6659649808708665
- 35 USC 102 Novelty (BERT): 0.7002741577544789
- Combined Prediction Score: 0.6693958985592278
- Mean Citation Score: 487.126922
- Max Citation Score: 935.623
- Similarity Product: 732.3737472138405

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test